News

The specialized module will optimize workflow and analysis pipeline when working with a huge number of antibodies during the development of new therapies including infectious diseases and cancer.

The settlement follows the Mylan litiagtion against the US Food and Drug Administration (FDA) regarding Mylan’s abbreviated new drug application for Modafinil Tablets, 100mg and 200mg. As a

The patent is entitled, Method for activating natural killer cells by tumor cell preparation in vitro and has a current expiration date of July 2027. CNDO-109 activates the

The Phase II trial will evaluate the clinical activity, safety and tolerability of multiple once-monthly doses of ALN-TTR02 in ATTR patients. Alnylam anticipates presenting data from the Phase

The company’s contract manufacturing organization is currently processing Epodure Biopumps for the treatment of anemia in a good manufacturing practice certified facility. Medgenics president and chief executive officer

The clinical studies reported that the supplement takes higher dosages of the African mango to create the weight loss effect shown in the studies. Irvingia Gabonensis is the

Particle Sciences focuses on BCS II/III/IV molecules, biologics and potent compounds through different technologies such as emulsions, gels, micro and nano-particulates, drug/device combination products, solid solutions and others.

According to updated monograph, Larch arabinogalactan is allowed for use in dietary supplements. The company offers larch arabinogalactan for immune health under the brand name ResistAid. Current clinical

A single 12-week principal efficacy trial and two supportive studies that met their respective primary endpoints evaluated the efficacy and safety of Horizant. A dosage of 600mg twice